Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Priority to UY26393ApriorityCriticalpatent/UY26393A1/en
Publication of UY26393A1publicationCriticalpatent/UY26393A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describen nuevos pirroles substituidos, que tienen la fórmula:(I) . Estos compuestos y sus sales farmacéuticamente aceptables son adecuadas para la administración a pacientes como solución para infusión continua y son de utilidad para el tratamiento y/o control de trastornos proliferativos celulares, en particular, del cáncer. También se describen composiciones farmacéuticas que contienen los compuestos anteriores y su empleo para el tratamiento y/o control del cáncer.Novel substituted pyrroles are described, having the formula: (I). These compounds and their pharmaceutically acceptable salts are suitable for administration to patients as a solution for continuous infusion and are useful for the treatment and / or control of cell proliferative disorders, in particular cancer. Pharmaceutical compositions containing the above compounds and their use for the treatment and / or control of cancer are also described.
DERIVATIVES OF FITTED HETERO-PENTACICLO-FENILO, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND USES TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF A CONDITION MEDIATED BY P38
"PIRROLO DERIVATIVES (3,4-C) PIRAZOL ACTIVE AS QUINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM."